• Health & Medicine

Three new cancer drugs approved for NHS in Scotland

The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma. The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.

21 January 2021

• Health & Medicine

NHS patients among first to access new CAR T cell therapy for lymphoma

Lymphoma patients in England are among the first in the world to be offered new CAR T cell therapy. Lymphoma patients in England are among the first in the world to be offered new CAR T cell therapy.

20 January 2021

• Health & Medicine

NICE approves new maintenance treatment for ovarian cancer

A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer. A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer.

19 January 2021

• Science & Technology
• Health & Medicine

Discovering the BRCA2 gene – 25 years on

25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off. 25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off.

14 January 2021

• Health & Medicine

Bowel scope screening to stop in England

Seven years after roll out began in England, bowel scope was still not being offered to everyone. And today, the test was removed from the roster. Seven years after roll out began in England, bowel scope was still not being offered to everyone. And today, the test was removed from the roster.

14 January 2021

• For Supporters

“We’re proud to work with an amazing charity”: Co-op Legal Services on raising £200k for our research

As Co-op Legal Services celebrates a new fundraising milestone raised for life-saving cancer research, we hear what our partnership means to them As Co-op Legal Services celebrates a new fundraising milestone raised for life-saving cancer research, we hear what our partnership means to them

14 January 2021

• Science & Technology

Scientists develop approach for exploiting cancer’s dietary demands

Scientists discover a way to target cancer’s nutritional needs, which could lead to a new way to treat the disease. Scientists discover a way to target cancer’s nutritional needs, which could lead to a new way to treat the disease.

13 January 2021

• Health & Medicine

Ultraviolet radiation causes rare type of eye cancer

Ultraviolet radiation can cause a rare type of eye cancer, conjunctival melanoma. Ultraviolet radiation can cause a rare type of eye cancer, conjunctival melanoma.

11 January 2021

• Health & Medicine

COVID-19 in people with cancer – what we know so far

More than 8 months since the pandemic began, we now have a clearer picture of how COVID-19 affects people with cancer. More than 8 months since the pandemic began, we now have a clearer picture of how COVID-19 affects people with cancer.

7 January 2021

• Health & Medicine

Striking differences seen in COVID-19 responses in cancer patients

A new study funded by Cancer Research UK shows that the immune response to COVID-19 is the same in people with solid tumours compared to those without cancer. A new study funded by Cancer Research UK shows that the immune response to COVID-19 is the same in people with solid tumours compared to those without cancer.

5 January 2021

• Policy & Insight
• Science & Technology

We have a Deal: What does the new UK-EU relationship mean for cancer?

Here’s what we know about how the new UK-EU relationship may affect cancer services and research. Here’s what we know about how the new UK-EU relationship may affect cancer services and research.

4 January 2021

• Charity News

Cancer Research UK appoints Professor Pamela Kearns as new Trustee

Cancer Research UK announce the appointment of Professor Pamela Kearns as a Trustee and Member. Cancer Research UK announce the appointment of Professor Pamela Kearns as a Trustee and Member.

4 January 2021